COMPARATIVE COST-MINIMIZATION AND BUDGET-IMPACT ANALYSIS OF FIXED-DOSE INHALED CORTICOSTEROID / LONG-ACTING BETAAGONIST COMBINATIONS IN THE TREATMENT OF ASTHMA

COMPARATIVE COST-MINIMIZATION AND BUDGET-IMPACT ANALYSIS OF FIXED-DOSE INHALED CORTICOSTEROID / LONG-ACTING BETAAGONIST COMBINATIONS IN THE TREATMENT OF ASTHMA

Comparative pharmacoeconomic analysis of fixed-dose combinations (FDC) vilanterol / fluticasone furoate vs budesonide / formoterol was needed to identify the preferable FDC for asthma management.Study objective: to identify the preferable FDC of inhaled corticosteroid/ longacting beta agonist combin...

Full description

Bibliographic Details
Main Authors: N. L. Pogudina, E. G. Kosolapov, F. S. Kochenkov, A. V. Karaulov, N. L. Bondarenko, D. V. Blinov
Format: Article
Language:Russian
Published: IRBIS LLC 2017-08-01
Series:Фармакоэкономика
Subjects:
asthma
inhaled corticosteroids
ics
long-acting beta agonists
laba
vilanterol
fluticasone furoate
budesonide
formoterol
fixed-dose combination
cost-minimization analysis
budget impact analysis
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/195

Internet

https://www.pharmacoeconomics.ru/jour/article/view/195

Similar Items